ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Nine Saturation Program Planning Contracts Approved

May 9, 1975

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

January 31, 2003

Largest Oncological Society Exerts Clout, Getting Results

June 24, 1983

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008